Recon: FDA places Legend Biotech’s early-stage CAR-T on hold; Lilly reunites with Immunogen with ADC deal
ReconJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesBiotechnologyDiagnostics/IVDsGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy